Literature DB >> 2832949

Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems.

T P Su1, E D London, J H Jaffe.   

Abstract

Specific sigma binding sites have been identified in the mammalian brain and lymphoid tissue. In this study, certain gonadal and adrenal steroids, particularly progesterone, were found to inhibit sigma receptor binding in homogenates of brain and spleen. The findings suggest that steroids are naturally occurring ligands for sigma receptors and raise the possibility that these sites mediate some aspects of steroid-induced mental disturbances and alterations in immune functions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832949     DOI: 10.1126/science.2832949

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  120 in total

1.  Pregnancy reduces brain sigma receptor function.

Authors:  R Bergeron; C de Montigny; G Debonnel
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP.

Authors:  P J Lupardus; R A Wilke; E Aydar; C P Palmer; Y Chen; A E Ruoho; M B Jackson
Journal:  J Physiol       Date:  2000-08-01       Impact factor: 5.182

3.  Pretreatment with aldosterone or corticosterone blocks the memory-enhancing effects of nimodipine, captopril, CGP 37,849, and strychnine in mice.

Authors:  C Mondadori; C Gentsch; B Hengerer; T Ducret; J Borkowski; A Racine; R Lederer; A Haeusler
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 4.  Sigma receptors: biology and therapeutic potential.

Authors:  Xavier Guitart; Xavier Codony; Xavier Monroy
Journal:  Psychopharmacology (Berl)       Date:  2004-06-10       Impact factor: 4.530

5.  Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N'-dimethyltryptamine forming enzyme, indole-N-methyl transferase.

Authors:  T A Mavlyutov; M L Epstein; P Liu; Y I Verbny; L Ziskind-Conhaim; A E Ruoho
Journal:  Neuroscience       Date:  2012-01-04       Impact factor: 3.590

Review 6.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

7.  The sigma-1 receptor chaperone as an inter-organelle signaling modulator.

Authors:  Tsung-Ping Su; Teruo Hayashi; Tangui Maurice; Shilpa Buch; Arnold E Ruoho
Journal:  Trends Pharmacol Sci       Date:  2010-10-01       Impact factor: 14.819

8.  Implications of immune system in stroke for novel therapeutic approaches.

Authors:  Aaron A Hall; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2010-01-13       Impact factor: 6.829

9.  Photoaffinity labeling of the sigma-1 receptor with N-[3-(4-nitrophenyl)propyl]-N-dodecylamine: evidence of receptor dimers.

Authors:  Uyen B Chu; Subramaniam Ramachandran; Abdol R Hajipour; Arnold E Ruoho
Journal:  Biochemistry       Date:  2013-01-28       Impact factor: 3.162

Review 10.  Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders.

Authors:  Teruo Hayashi; Tsung-Ping Su
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.